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From the Cradle to the Grave: The 
Role of Macrophages in erythropoiesis 
and erythrophagocytosis
Thomas R. L. Klei†, Sanne M. Meinderts†, Timo K. van den Berg and Robin van Bruggen*
Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, University of Amsterdam, Amsterdam, 
Netherlands
Erythropoiesis is a highly regulated process where sequential events ensure the proper 
differentiation of hematopoietic stem cells into, ultimately, red blood cells (RBCs). 
Macrophages in the bone marrow play an important role in hematopoiesis by providing 
signals that induce differentiation and proliferation of the earliest committed erythroid 
progenitors. Subsequent differentiation toward the erythroblast stage is accompanied by 
the formation of so-called erythroblastic islands where a central macrophage provides 
further cues to induce erythroblast differentiation, expansion, and hemoglobinization. 
Finally, erythroblasts extrude their nuclei that are phagocytosed by macrophages 
whereas the reticulocytes are released into the circulation. While in circulation, RBCs 
slowly accumulate damage that is repaired by macrophages of the spleen. Finally, after 
120 days of circulation, senescent RBCs are removed from the circulation by splenic and 
liver macrophages. Macrophages are thus important for RBCs throughout their lifespan. 
Finally, in a range of diseases, the delicate interplay between macrophages and both 
developing and mature RBCs is disturbed. Here, we review the current knowledge on 
the contribution of macrophages to erythropoiesis and erythrophagocytosis in health 
and disease.
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iNTRODUCTiON
Red blood cell (RBC) turnover is a complex process that is regulated at different levels by 
many factors, particularly by macrophages. Macrophages shape and direct the developing RBC 
throughout erythropoiesis and ultimately phagocytose senescent RBCs. To perform these tasks, 
macrophages rely on adhesion molecules, a range of soluble and mechanical factors, and it 
Abbreviations: AIHA, autoimmune hemolytic anemia; BFU-e, burst-forming unit-erythroid cells; BMP4, bone morphogenetic 
protein 4; CFU-e, colony-forming unit-erythroid cells; CSF-1, macrophage colony-stimulating factor; DT, diphtheria toxin; 
EMH, extramedullary hematopoietis; Emp, erythroblast macrophage protein; Epo, erythropoietin; EpoR, erythropoietin recep-
tor; G6PD, glucose-6-phosphate dehydrogenase; GAS-6, growth-arrest specific 6; GC, glucocorticoids; G-CSF, granulocyte 
colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; GpA, glycophorin-A; HO-1, heme-
oxygenase 1; HSC, hematopoietic stem cell; ICAM-4, intercellular adhesion molecule 4; INF-γ, interferon-γ; IGF-1, insulin-like 
growth factor-1; IL-3, interleukin-3; Nabs, natural occurring antibodies; PGF, placental growth factor; PS, phosphatidylserine; 
PV, polycythemia vera; RBC, red blood cell; SIRPα, signal-regulatory protein alpha; SRCR, scavenger receptor cysteine rich; 
TGF-β, transforming growth factor-β; TNF-α, tumor necrosis factor-α; TRF-1, transferrin receptor-1; VCAM-1, vascular cell 
adhesion molecule-1; VEGF-A, vascular endothelial growth factor A.
FiGURe 1 | Macrophages and erythroblasts form erythroblastic 
islands through adhesion molecules. Macrophages express several 
adhesion molecules that facilitate interactions with erythroid precursors of 
various stages. The intercellular adhesion molecule 4 (ICAM-4) and the α4β1 
integrin on erythroblasts interact with the αVβ1 integrin and vascular cell 
adhesion molecule-1 (VCAM-1) on the macrophage. Gradual loss of the α4β1 
integrin and EMP on the erythroblast facilitates the release of reticulocytes 
from the erythroblastic island. Persistence of these adhesion molecules on 
the pyrenocytes is contributing to its phagocytosis by the central 
macrophage.
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requires cross talk with the developing or senescent RBC. 
Here, we review the role macrophages in erythropoiesis and 
erythrophagocytosis in health and disease.
MACROPHAGe FUNCTiON iN 
eRYTHROPOieSiS
Erythropoiesis is a highly coordinated and regulated process 
that consists of defined developmental stages, which are regu-
lated by macrophages in a variety of ways. First, macrophages 
retain hematopoietic stem cells (HSCs) in the hematopoietic 
niche. Growth factors and cytokines including interleukin-3 
(IL-3) and granulocyte-macrophage colony-stimulating factor 
(GM-CSF) facilitate proliferation and differentiation of the earli-
est primitive erythroid progenitor cells, so-called burst-forming 
unit-erythroid cells (BFU-e) (1). These slowly proliferating 
erythroid progenitors can then, under the influence of kidney-
derived erythropoietin (Epo), differentiate into rapidly dividing 
colony-forming unit-erythroid cells (CFU-e) (2). Subsequent 
differentiation into the erythroblast stage is accompanied by 
the formation of so-called erythroblastic islands. Here, a central 
macrophage interacts with up to 30 erythroblasts through vari-
ous adhesion molecules both on the macrophage as well as on the 
erythroblasts (3). In these erythroblastic islands, macrophages 
facilitate erythroblast proliferation, differentiation, and are 
involved in iron supply. Finally, macrophages phagocytose and 
digest the nuclei extruded by erythroblasts during their transi-
tion to the reticulocyte stage (4).
MACROPHAGeS AND eRYTHROBLASTS 
FORM eRYTHROBLASTiC iSLANDS 
THROUGH iNTeRCeLLULAR ADHeSiON 
MOLeCULeS
Erythroblastic islands can be found in all tissue compartments 
that support erythropoiesis including the yolk sac, fetal liver, 
bone marrow, and in certain cases the splenic red pulp (5). They 
are important for proper erythropoiesis as depletion of bone mar-
row macrophages, or interference with the adhesion molecules 
that contribute to the formation of erythroblastic islands, leads 
to pro-erythroblast differentiation arrest, a reduction in prolifera-
tion, increased apoptosis, and ultimately anemia (6–8). Several 
adhesion molecules have been identified that are important for 
formation and stabilization of erythroblastic islands and thus for 
erythropoiesis (Figure 1).
One of the first adhesion molecules described to be important 
for erythroblastic island formation is erythroblast macrophage 
protein (Emp). Emp is expressed both on the central macrophage 
as well as on the erythroblast (9). The homotypic interaction 
between Emp on the macrophage and Emp on the erythroblast is 
one of the prerequisites for efficient erythropoiesis since interfer-
ing with this interaction, using blocking antibodies, decreases 
proliferation and results in increased erythroblast apoptosis 
(10). Even though macrophages have been shown to be able to 
interact with Emp-null erythroblasts, these erythroblasts do not 
enucleate, underlining the importance of this adhesion molecule 
in erythropoiesis.
Next to Emp, several other adhesion molecules are impor-
tant in the formation of stable erythroblastic islands. These 
include the α4β1 integrin and intercellular adhesion molecule 4 
(ICAM-4) expressed on erythroid precursors. These molecules 
interact with vascular cell adhesion molecule-1 (VCAM-1) 
and αV integrins, respectively, such as αVβ1 and αVβ5 (11). By 
interfering with the interactions between these receptor pairs 
by use of blocking antibodies, it was found that these adhesion 
molecules are important for erythroblastic island integrity. 
Interfering with the ICAM-4–αV integrin interaction was shown 
to lead to a reduction in erythroblastic island number as well 
as the total number of erythroblasts per island (6). Similarly, 
loss of α4β1-VCAM-1 interaction led to erythroblastic island 
disruption (8). Since abrogation of the ICAM-4–αV integrin 
binding was found to lead to reduced interaction between 
erythroblasts and macrophages, and since ICAM-4 expression 
is decreasing during erythropoiesis, the discovery of a secreted 
form of ICAM-4, ICAM-4S, prompted the hypothesis that 
ICAM-4S is involved in the release of terminally differentiated 
erythroblasts from the erythroblastic island (12).
Apart from promoting erythroblastic island stability and 
formation, several adhesion molecules found on the central 
macrophages, such as CD163 and CD169, have been shown 
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to promote proliferation. CD163 consists of nine so-called 
scavenger receptor cysteine rich (SRCR) domains. The third 
SRCR domain within CD163 functions to scavenge hemo-
globin–haptoglobin complexes from the circulation (13). 
A  13 amino acid motif within the second scavenger domain 
of CD163 was found to directly interact with erythroblasts 
(14). It was furthermore established that CD163 interaction 
with erythroblasts promoted expansion but not differentiation. 
This was shown to be dependent on the maturation stage of 
the erythroblast as the interaction between macrophage CD163 
and the erythroblast is quickly lost past the pro-erythroblast 
stage, indicating that its function is to regulate early pro-survival 
signals.
The counter receptor for CD163 on the erythroblast has not 
yet been identified. What is known is that upon interaction of 
CD163 with the hemoglobin–haptoglobin complex, a cascade 
of intracellular signaling is induced within the macrophage, 
including calcium mobilization and inositol triphosphate 
production. Subsequently, through an autocrine feedback 
loop, the secretion of interleukin-6 and macrophage colony-
stimulating factor (CSF-1) leads to macrophage survival (15). 
It is of interest to assess whether these, or similar downstream 
signaling events, also occur after binding of erythroblasts and 
thus stimulate macrophage survival through CSF-1, indirectly 
aiding erythroblast expansion. Another macrophage adhesion 
molecule that is important for erythropoiesis is CD169 (16), a 
surface molecule originally identified as the “sheep erythrocyte 
receptor” or sialoadhesin, based on its capacity to recognize 
sialic acid residues (17). An interesting study by the group of 
Jacobsen showed the importance of CD169+ macrophages in 
erythropoiesis. In this study, treatment of mice with granulocyte 
colony-stimulating factor (G-CSF) was found to impair bone 
marrow erythropoiesis. Searching for the underlying cause 
they established that bone marrow macrophage numbers were 
greatly reduced. Characterization of bone marrow macrophages 
showed that CD169+ but not CD169− macrophages were lost 
upon G-CSF treatment (7). Currently, it is unclear why CD169+ 
macrophages in the bone marrow are mainly affected, especially 
since G-CSF treatment did not ablate CD169+ macrophages in 
the spleen. It was furthermore established that splenic CD169+ 
macrophages, upon CD169+ macrophage depletion from the 
bone marrow, could facilitate extramedullary hematopoiesis 
(EMH) in the spleen which is speculated to compensate for 
the G-CSF induced dyserythropoiesis in the bone marrow. 
In polycythemia vera (PV), where the Janus Kinase V617F 
mutation JAK2(V617F) is hyper  sensitizing erythroid pre-
cursors to EPO, the depletion of CD169+ macrophages was 
found to reduce splenomegaly and reticulocytosis resulting in 
normalization of the erythroid compartment in mice (16). This 
finding indicates that erythropoiesis in PV is still sensitive to 
the stimulating activity of macrophages and identifies these 
macrophages as a potential therapeutic target to counteract 
the exaggerated erythropoiesis induced by the JAK2(V617F) 
mutation. Another chronic stress condition resulting in anemia 
is beta-thalassemia (18). In this disease, the absence or reduced 
expression of β-globin chains causes excess α-globin chains 
to precipitate in RBCs and precursors, leading to premature 
RBC destruction and ultimately anemia. High Epo levels here 
result in increasing erythroblast numbers. To facilitate the high 
rate of erythropoiesis, iron absorption is increased which in 
chronic situations leads to toxic iron overload. Ablation of 
CD169+ macrophages in a PV mouse model using clodronate 
liposomes broke this cycle of continuous-accelerated inefficient 
erythropoiesis. Already 40  h after clodronate treatment, an 
improvement of the anemia was observed (19). Within the 
bone marrow and spleen, the depletion of macrophages led to 
a reduction of erythroid progenitors and a proportional increase 
in differentiated erythroid cells. This clearly shows that although 
Epo/EpoR/JAK2 are master regulators in erythrocytosis in PV, 
CD169+ macrophages play an important role in the exagger-
ated levels of erythropoiesis during chronic stress conditions, 
which is ameliorated upon macrophage depletion. How exactly 
CD169+ macrophages exert this proliferative potential upon 
erythropoiesis is still not clear. What is known though is that 
CD169+ macrophages are pivotal in retaining HSCs in the bone 
marrow mesenchymal stem cell niche (20). Furthermore, also 
during later stages of hematopoietic development, CD169+ 
macrophages are important for erythroid proliferation. This 
was addressed in a study where through electron micros-
copy it was found that CD169+ macrophages induced loose 
interactions with erythroblasts leading to the formation of 
erythroblastic islands, allowing rapid proliferation and inducing 
pro-erythroblast cytokinesis (21). In contrast, CD169− mac-
rophages engaged tight interactions with erythroblasts leading 
to erythroblast phagocytosis and impaired proliferation (21). 
How, mechanistically, CD169+ macrophages induce cytokinesis 
is still subject to investigation. However, an interesting candi-
date to direct future research toward is Mucin-1 as it was found 
to act as a ligand for CD169 (22). This heavily O-glycosylated 
protein is gradually expressed during erythropoiesis and found 
to be absent in RBCs. Similar to other known SIGLECs, the 
cytoplasmic tail of CD169 contains tyrosine motifs that induce 
intracellular signaling upon ligation. Upon ligation of CD169 
by antibody crosslinking, clathrin-mediated endocytosis was 
observed (23). Current focus regarding CD169-mediated 
endocytosis involves toxins and lipid antigen uptake, as a 
means of antigen internalization and ultimately presentation. 
It would be of interest to determine how CD169 on macrophages 
contributes to proliferation of erythroblasts.
SeCReTiON OF SOLUBLe FACTORS 
iMPORTANT iN eRYTHROBLASTiC 
iSLANDS
Various soluble factors have been identified that are important 
in defined stages of erythropoiesis. Within erythroblastic islands, 
both macrophages and erythroblasts secrete, or are dependent 
on, soluble factors. Some of these factors have been found to be 
important for erythroblastic island integrity, but some also for 
proliferation, differentiation, and hemoglobinization of RBC 
precursors.
Macrophages and erythroblasts cross-stimulate each other 
to promote proliferation. Macrophages have, for example, been 
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shown to secrete insulin-like growth factor-1 and bone mor-
phogenetic protein 4 (BMP4) to stimulate BFU-e and CFU-e 
proliferation (24, 25). On the other hand, erythroblasts secrete 
vascular endothelial growth factor A placental growth factor 
and growth-arrest specific 6 that are thought to aid macrophage 
proliferation (26–29). Another factor that is important for eryth-
ropoiesis is ferritin. In splenic and bone marrow macrophages 
but also hepatocytes and Kupffer cells, excess iron is stored in 
this globular protein (30). It was found that bone marrow and 
spleen derived macrophages, in absence of transferrin, could 
synthesize ferritin and excrete it. Subsequently, erythroid pre-
cursors were found to internalize ferritin through endocytosis, 
surprisingly, through transferrin receptor-1 (31–33). Some 
findings suggest that macrophages directly supply ferritin to 
surrounding developing erythroblasts. Ferritin molecules were, 
for example, found to be localized between the membranes of the 
central erythroblastic island macrophage and the erythroblast 
(34). However, in mice, serum ferritin was found to contain low 
levels of iron. It is thus questioned whether serum-derived fer-
ritin contributes, in any significant way, to hemoglobin synthesis 
in erythroid precursors (32).
Aside from factors positively influencing erythroid and 
macrophage proliferation, several secreted factors negatively 
regulate erythropoiesis. These include the cytokines trans-
forming growth factor-β (TGF-β), tumor necrosis factor-α 
(TNF-α), and interferon-γ (INF-γ) (35–38). INF-γ and TNF-α 
negatively regulate erythropoiesis mainly through induction of 
apoptosis (37, 39). Production of TNF-α by macrophages, for 
example, induces caspase-mediated cleavage of transcription 
factor GATA-1 (37). GATA-1 is critical for pro-erythroblast 
differentiation. This is not only illustrated by the observation 
that pro-erythroblasts from chimeric GATA-1 knockout mice 
fail to mature beyond this stage and go into apoptosis (40) but 
also by individuals carrying mutations in the GATA1 gene who 
suffer from dyserythropoietic anemia (41–43). Production of 
TGF-β by macrophages negatively regulates erythropoiesis quite 
differently. It was found that TGF-β markedly accelerated and 
increased erythroid differentiation but at the same time induces 
loss of proliferative potential in RBC precursors thereby causing 
erythropoietic arrest (36).
Besides positive and negative regulators of normal eryth-
ropoiesis, several secreted factors have been identified that 
are important during stress erythropoiesis, as is found during 
anemia due to trauma or sepsis. In stress erythropoiesis, RBC 
output by CFU-e cells is insufficient due to the limited amount 
of divisions these cells undergo. BFU-e progenitor cells in such 
conditions are therefore induced to form new CFU-e cells. 
Several factors have been identified that play a role during 
stress erythropoiesis. These factors include glucocorticoids 
(GC), BMP4, and stem cell factor (44–46). Mice lacking the 
GC receptor, for example, display normal erythropoiesis but are 
incapable of inducing stress erythropoiesis as they fail to induce 
CFU-e proliferation in the spleen as seen in wild-type mice (44). 
Similarly, BMP4 expression in the spleen, as a response to acute 
anemia, was found to drive differentiation of immature progeni-
tors into so-called stress BFU-e cells, allowing rapid expansion 
and erythropoiesis (47).
MACROPHAGeS SUPPORT TeRMiNAL 
DiFFeReNTiATiON iN eRYTHROPOieSiS
The last stages of erythroid development include the expulsion 
of the nucleus and membrane remodeling of the nascent reticu-
locyte in the circulation (48–50). Macrophages phagocytose 
expelled nuclei in the bone marrow and facilitate the maturation 
process of circulating reticulocytes in the spleen.
One of the key elements in the clearance of the expelled 
nuclei, the so-called pyrenocytes, by macrophages, is the 
sorting process of membrane proteins. During nuclear extru-
sion, proteins are selectively being directed toward either the 
reticulocyte or pyrenocyte membrane. Cytoskeletal proteins 
and integral membrane proteins important for RBC shape and 
deformability such as ankyrin, spectrin, and the glycophorins are 
sorted toward the reticulocyte membrane. On the other hand, 
proteins associated with cellular adhesion such as Emp1 and 
β1 integrins are sorted toward the pyrenocyte (48). Although 
it is currently unclear how this sorting process works, it is 
hypothesized that cytoskeletal interactions play an important 
role since protein sorting is defective in disorders such as 
elliptocytosis, spherocytosis, and sickle cell disease (51, 52). 
It is clear, however, that during terminal maturation, proteins 
in the RBC membrane undergo dramatic reorganization. The 
sorting of adhesive molecules Emp and β1 integrins toward the 
pyrenocyte allows for the interaction with macrophage Emp and 
VCAM-1, respectively. In addition, it is thought that a combina-
tion of ATP depletion and concomitant phosphatidylserine (PS) 
exposure signals the macrophage through one of its PS receptors 
to phagocytose the pyrenocyte (53).
Finally, reticulocytes are released into the circulation where 
they mature into RBCs. During this stage, reticulocytes lose 
volume, become biconcave, and acquire the typical flexibility 
of an RBC (54, 55). Furthermore, expression of the transferrin 
receptor is quickly downregulated through exosome release to 
prevent excessive iron import and toxicity (56). It is thought that 
red pulp macrophages (RPMs) of the spleen play an important 
role in this maturation process, as depletion of macrophages by 
clodronate treatment inhibits the maturation of reticulocytes 
in the circulation (57). How splenic macrophages come into 
contact with early reticulocytes and promote their maturation 
into RBCs is still not clear. One hypothesis involves a mechanism 
similar to recognition of aged RBCs, a process that is described 
more extensively below, and is based on the capacity of the red 
pulp of the spleen to filter out rigid RBCs. A characteristic that 
old RBCs and reticulocytes share is a relative lack of deform-
ability. Treatment of healthy RBCs with agents that alter their 
deformability, such as chloroquine, leads to RBC accumulation 
in the spleen (58). Thus, reticulocytes may be trapped in the 
spleen by their lack of deformability, thereby coming into close 
proximity to the RPMs. A protein that seems to be involved in 
reticulocyte maturation and differentially regulates membrane 
stiffness of reticulocytes and RBCs is glycophorin-A (GpA). It 
was found that in reticulocytes GpA is strongly interacting with 
the underlying cytoskeleton and thereby largely contributes to 
membrane rigidity. In terminally differentiated RBCs, however, 
the interaction with the cytoskeleton is less prominent, resulting 
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in a more deformable membrane (59). It is therefore postulated 
that the spleen acts as sieve where non-deformable cells are cap-
tured and that, here, macrophages await to facilitate reticulocyte 
remodeling.
ROLe OF MACROPHAGeS iN eMH
Hematopoiesis occurring outside the bone marrow is referred to 
as EMH. In healthy mice, roughly 10% of erythropoietic output 
is facilitated by the spleen (60). In human spleen, although 
some hematopoietic elements are usually present, it is generally 
accepted that, during steady state, its contribution to hemat-
opoiesis is negligible (61, 62). There are certain circumstances 
during which EMH occurs. During fetal development, for exam-
ple, EMH occurs in the yolk sac, fetal liver, and spleen (63–65). 
In adulthood, bone marrow abnormalities including overpro-
duction of marrow elements, damage to the bone marrow, or 
alterations in cellular bone marrow constituents can cause EMH. 
Also, prolonged hypoxic conditions, chronic inflammation and 
infection, and genetic disorders can contribute to EMH (66).
A commonly used agent to induce and study EMH is G-CSF. 
G-CSF treatment in mice leads to the depletion of macrophages 
from the bone marrow, by a mechanism that is still obscure. 
In these mice, erythropoiesis is arrested at the pro-erythroblast 
stage. It is well recognized that this causes EMH (67). It is 
believed that mobilization of HSC to the spleen, especially, 
when G-CSF treatment is combined with cyclophosphamide 
treatment is contributing to EMH (68). Macrophages play a 
key role in capturing the mobilized HSCs through vascular 
VCAM-1 (69).
Additional to retaining HSCs in the spleen, macrophages were 
found to play a central role in ongoing EMH. Hepatic sinusoidal 
macrophages were found to form erythroblastic islands upon 
induction of anemia in mice by injection of phenyl hydrazine 
(70). To assess the importance of CD169+ macrophages in 
EMH of the spleen and bone marrow, a mouse model was used 
where the diphtheria toxin receptor (DTR) was knocked-in 
downstream of the Siglec 1 promotor, a protein found specifi-
cally in macrophages. Treatment of these CD169DTR/+ mice 
with diphtheria toxin leads to ablation of these macrophages. 
Short exposure to DT resulted in CD169+ macrophage ablation 
from bone marrow but not from spleen. Using phenylhydrazine 
it was found that splenic VCAM-1, an adhesion molecule 
facilitating erythroblastic island interactions, on CD169+ bone 
marrow macrophages, was critical to recover from hemolytic 
anemia (16).
EMH can also be observed during infection. Systemic infec-
tion by E. coli in mice was found to lead to a 744-fold increase in 
G-CSF serum levels, directly inducing HSC mobilization to the 
spleen (71). Similarly, S. aureus was shown to induce production 
of IL-3 and GM-CSF in spleen cell cultures of mice (72). In hema-
globinopathies such as β-thalassemia and sickle cell disease, the 
premature destruction of RBCs and erythroid precursors causes 
anemia, overproduction of Epo and ultimately EMH in spleen 
and liver (73). Since in these diseases the erythroid progenitors 
are susceptible to apoptosis, increased Epo levels here do not 
compensate the anemia.
Taken together, disease, infection, and genetic disorders all can 
lead to EMH of which the underlying mechanism is not always 
clear. During anemia, the body attempts to increase erythropoiesis 
by excretion of hematopoietic factors and mobilization of HSCs 
to other tissues such as the spleen. Here, macrophages can trap 
HSCs through, amongst others, VCAM-1 and in the presence 
of the right factors initiate erythroblastic island formation and 
EMH. The relationship between anemia and EMH is intimate but 
still not well understood at the molecular level. Future studies 
may shed further light on the factors that drive EMH.
RePAiR AND CLeARANCe OF RBC BY 
MACROPHAGeS iN THe SPLeeN
After their development in the bone marrow, RBCs have a life 
span of approximately 120  days (74), during which they have 
numerous interactions with macrophages of the spleen and 
liver. With time the plasma membrane of the RBC undergoes 
deleterious changes that make the cell susceptible to clearance 
by macrophages (75). The spleen is the primary organ to filter 
effete RBC out of the blood. It is anatomically divided in red pulp, 
which is responsible for the filtering function, and white  pulp, 
which is dedicated to adaptive immunity. The red and white 
pulp are divided by the marginal zone (76). With its specialized 
structure of the venous system, the red pulp of the spleen has the 
unique capacity to retain old RBC that has become less deform-
able (74, 75). The membrane of RBCs is extremely elastic. This 
deformability is of great importance since it allows RBCs to pass 
through capillaries that are narrower than their own diameter 
(77, 78). Over time, RBCs lose their elasticity. RPMs located in 
the cords of the red pulp phagocytize the RBCs that are too rigid 
to pass through the inter-endothelial slits of the red pulp (74). The 
high percentage of macrophages in the red pulp and the unique 
structure of the spleen give it its specialized ability to scrutinize 
the integrity of RBCs (75). Decreased RBC deformability is not 
only a characteristic of senescent RBCs (79). In many pathological 
conditions such as sickle cell disease, hereditary spherocytosis, 
or sepsis RBC clearance is enhanced due to rigidification of the 
RBC membrane (80–84). Stiffening of the RBC membrane is also 
observed in malaria which is discussed below. On the opposite 
side, hyperactivation of macrophages may also lead to enhanced 
clearance. This can occur for instance in the hyperinflammatory 
syndromes, hemophagocytic lymphohistiocytosis (HLH) (85). 
HLH is a rare disorder that is characterized by spiking fevers 
and hemophagocytosis by activated macrophages (86). It can 
be caused by various disorders which can be hereditary or sec-
ondary to several pathologies such as infection, malignancy, or 
autoimmune disease (87). Depending on the background of the 
disease, numerous mechanisms have been proposed to explain 
hemophagocytosis in HLH. It is suggested that in most if not all 
forms of HLH, the hyperactivation of macrophages is caused by 
a cytokine storm induced by uncontrolled activated NK cells and 
cytotoxic T-lymphocytes (88).
In addition to inspecting RBC membrane deformability, 
macrophages also remove inclusion bodies from circulating 
RBCs (89). Already in the late 1950s, it was shown that this pro-
cess is exclusively executed in the spleen. Crosby et al. showed 
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that injected-labeled siderocytes (RBCs containing iron filled 
granules) in subjects with a spleen decreased over time while 
in splenectomized subjects the amount of siderocytes remained 
unchanged (89). Moreover, splenectomized patients show a high 
amount of RBCs with Howell-Jolly bodies (nuclear chromatin 
inclusions), Heinz bodies (inclusions of denatured hemoglobin), 
siderocytes, and Pappenheimer bodies (inclusions formed by 
phagosomes that have taken up excessive amounts of iron) (90). 
Hence, it seems that the spleen and its residing RPMs not only 
clear senescent RBCs but are also responsible for keeping RBC 
“healthy.” RBCs contain a variety of enzymes to protect the cell 
from oxidative damage. Yet, RBCs are not capable of synthesiz-
ing new proteins and in time oxidative damage will accumulate 
resulting in the formation of inclusion bodies (91). The exact 
mechanism underlying the removal of these inclusion bodies is 
not known, but it has been proposed that RBC vesiculation is 
involved in the disposal of RBC damage (92).
ReD PULP MACROPHAGeS
The RPMs are extremely potent in neutralizing the toxic effects 
of hemoglobin. They express high levels of the hemoglobin scav-
enger receptor CD163 and the enzyme heme-oxygenase 1 (HO-
1), which plays a crucial role in heme degradation (13, 76, 93). 
Recycling of iron through erythrophagocytosis by macrophages 
is the largest contributor to iron homeostasis. After phagocytosis 
of senescent RBCs, hemoglobin is degraded into heme and iron 
after which it is exported through ferroportin into the plasma. 
Here, transferrin traffics iron to cells that require iron including 
developing erythroid cells in particular [reviewed in Ref. (94)]. 
HO-1 is one of the critical enzymes in this cascade. Its absence 
leads to splenic and liver macrophage apoptosis and concomitant 
release of non-metabolized heme. In the spleen, this leads to red 
pulp fibrosis, atrophy, and ultimately functional aspleny (95).
The origin of RPMs is a current point of discussion. Recent 
studies by Geissmann et al. suggest that primitive macrophages 
originate from the yolk sac (96). However, subsequent studies 
propose that fetal HSCs give rise to RPMs (76, 97–99). The 
general view is that in the homeostatic situation macrophage 
populations are maintained by local proliferation. Nonetheless, 
in pathological conditions, such as infection and inflammation, 
circulating monocytes may enter the spleen and differentiate 
into RPMs (99–101). It seems that in inflammatory situations, 
the “steady-state” macrophage populations are substituted for an 
inflammatory monocyte derived pool of macrophages. Besides 
macrophages also other phagocytes may contribute to RBC clear-
ance in pathological situations. Stijlemans et al. show that in mice 
trypanosomiasis, a parasitic disease, increases erythrophagocy-
tosis by neutrophils and monocytes (102). This indicates that 
besides macrophages other phagocytes can play a role in RBC 
clearance during infection.
CLeARANCe OF BLOOD-BORNe 
iNFeCTiONS iN THe SPLeeN
The primary function of RPMs is believed to be the scavenging 
of senescent RBCs. Nevertheless, besides their homeostatic role, 
RPMs are important to control blood-borne diseases through 
their ability to control iron availability for infecting pathogens. 
Several diseases are associated with loss of RPMs due to for 
instance auto-splenectomy as observed in SCD. A combination 
of factors causes functional asplenism in these patients. First, 
slow RBC circulation speeds and high oxygen extraction rates 
cause the RBCs to sickle. Mechanical obstruction by sickled 
RBCs but also adhesion of RBCs to endothelium obstructs red 
pulp sinuses of the spleen and can contribute to infarction and in 
the long-term functional aspleny (103, 104). Since macrophages 
in the spleen play a key role in removing both senescent RBCs 
as well as blood-borne pathogens from the circulation, the func-
tional aspleny causes these patients to become more susceptible 
to blood-borne infections. Moreover, in SCD and thalassemia 
patients, or in patients suffering from iron overload in general, 
infection by pathogens such as Y. enterocolitica but also to strepto-
cocci is often observed (105, 106). Besides taking up whole RBC, 
macrophages can also take up immune complexes or pathogens 
bound to complement receptor 1 on RBCs while leaving the RBC 
intact, a process termed immune adherence clearance (107).
Red pulp macrophages are suggested to be specifically impor-
tant in the control of Plasmodium-infected RBCs. Malaria is the 
most frequently acquired infection affecting RBC and has a major 
impact on RBC deformability (75). Plasmodium parasites have a 
complex life cycle that starts off in hepatocytes and is followed 
by asexual stages in the RBC. This involves major restructuring 
of the RBC membrane and cytoskeleton (108). While the young 
asexual stages do not impact RBC deformability to a great extent, 
the mature asexual stages of the parasite cause stiffening of the 
RBC membrane, which makes them susceptible for removal in 
the spleen (75). Splenectomized mice show increased suscepti-
bility toward Plasmodium chabaudi infections (109). Moreover, 
Couper et  al. show that macrophage depletion in Plasmodium 
yoelii-infected mice results in exacerbated parasite growth and 
more profound anemia (110). These findings indicate a vital role 
of macrophages in the spleen in malaria infections. Although it 
is generally believed that RPMs play a central role in control of 
malaria infections, the extent of their importance is debatable. 
Studies show that parasitized RBCs are found in the red pulp 
(109), RPMs can remove parasites internalized by the RBC while 
leaving the RBC intact, a process called pitting (111), and RPMs 
expand during malaria infections (112). However, Kim et al. show 
that while RPMs produce large amounts of type I interferons 
during P. chabaudi infections Spic−/− mice, which lack RPMs 
completely, eliminate the parasite as efficiently as Wt mice (112). 
It was concluded that RPMs contribute to early immune infec-
tion recognition and activation, while they may be dispensable 
for control of the infection due to compensation by infiltrating 
monocytes.
RBC CLeARANCe iN THe LiveR
Besides the spleen also the liver is an important RBC depot 
and has an important role in RBC clearance and iron recycling 
(102, 113, 114). Current research suggests that under patho-
logical conditions the liver and not the spleen is the primary 
site of RBC clearance. Theurl et al. show in a mouse model that 
FiGURe 2 | “eat me” and “don’t eat me” signals involved in interaction 
between macrophages and red blood cell (RBC) regulating clearance. 
RBCs and macrophages interact with each other through ligand–ligand 
interactions. Over time, “eat me” signals accumulate on the RBC membrane. 
Phosphatidylserine (PS) exposed on the RBC membrane can directly bind 
Stabilin-2, Tim-1, Tim-4, or CD300 on the macrophages and is presumed to 
give a pro-phagocytic signal. Moreover, bridging molecules such as GAS-6 
and lactadherin can facilitate RBC-macrophage interaction by binding PS on 
RBCs and TAM receptors or αvβ3/β5 integrins on the macrophage. Band 3 
clustering and opsonization with Nabs and complement on the RBC enables 
binding to the macrophage via Fc receptors and CR-1 and thereby facilitates 
phagocytosis. As a counterbalance, CD47–SIRPα interactions inhibit 
phagocytosis of RBCs by the macrophage.
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infused-stressed RBCs predominantly end up in the liver (114). 
The presence of stressed or damaged RBCs led to a rapid recruit-
ment of monocytes. These monocytes give rise to “transient 
macrophages” that are well equipped to phagocytose RBCs and 
recycle the iron. This specific macrophage population was only 
found in the liver, and the researchers suggest that therefore the 
liver is uniquely adapted to respond to an increased demand for 
RBC phagocytosis. This hypothesis is supported by the work of 
Stijlmans et al. in which it is shown in mice that LPS injection 
or T. brucei infection leads to enhanced erythrophagocytosis 
primarily in the liver (102).
BAND 3-MeDiATeD CLeARANCe OF RBC 
BY MACROPHAGeS
Red blood cell clearance can be viewed as a two component 
process. On the one hand, mechanical retention and RBC 
deformability determine if an RBC gets cleared from the 
circulation; on the other hand, cell biological factors are 
involved in RBC removal through erythrophagocytosis in 
the spleen. So-called “eat me” signals accumulate on the cell 
membrane of the RBC over time, and these signals can trigger 
RBC clearance by macrophages (Figure 2) (115–117). There is 
no clear consensus about what these “eat me” signals exactly 
are (113). Yet, there have been several proposed mechanisms 
of RBC clearance. Firstly, it has been suggested that band 3, 
a highly abundant transmembrane protein, is the main target 
of natural occurring antibodies (Nabs) (116, 118, 119). Nabs 
are antibodies present in the serum of healthy individuals that 
have been formed without the apparent antigen exposure, for 
instance, anti-A antibodies in B-positive individuals (120). 
These immunoglobins are preferentially of the IgM isotype, and 
their production already starts before birth by B cells of the B1 
type in the marginal zones of the spleen (121). Nabs recognize 
self-, altered-self, and foreign antigens. Besides protecting from 
invading pathogens they are important regulators for clear-
ance of necrotic or apoptotic cells (122). Over time, band 3 is 
believed to be modified mostly due to oxidative damage, which 
leads to the formation of epitopes for Nabs binding (118, 123). 
The exact nature of epitope formation allowing Nab binding 
is still under debate. It is hypothesized that oxidative damage 
to hemoglobin leads to the formation of hemichromes (hemo-
globin denaturation products), which bind to band 3 and cause 
band 3 clustering. This in turn results in Nab binding (124). An 
alternative hypothesis for band 3 epitope recognition by Nabs 
is proteolytic degradation of band 3 (119). Kay et  al. showed 
that IgG eluted from scenescent RBCs rebound to proteolytic 
fragments of band 3. This led to the hypothesis that a cell-age-
specific antigen is exposed by a proteolytic modification (125). 
Due to their low affinity and low numbers in the circulation, 
Nabs are not efficient opsonins. It has been proposed that eryth-
rophagocytosis can be enhanced by complement activation 
through the classical pathway after opsonization of RBCs with 
Nabs (116). Complex formation between Nabs and complement 
C3 fragments is potent opsonins that are readily recognized by 
complement receptors on macrophages (and other phagocytes) 
(123, 126, 127).
OXiDATive STReSS/BAND 3-MeDiATeD 
CLeARANCe iN DiSeASe
In the homeostatic situation, RBC removal and erythropoiesis 
is balanced. In pathological situations, the oxidative insults 
modifying band 3 can be rapid and massive leading to accel-
erated RBC removal. Glucose-6-phosphate dehydrogenase 
(G6PD) deficiency is an example of a genetic RBC defect that 
exhibits insufficient antioxidant defense and hence anemia due to 
enhanced RBC destruction (118). G6PD is an enzyme involved 
in the production of NADPH, a cofactor used in anabolic reac-
tions. NADPH is crucial for the protection of the cell against 
oxidative stress (128). Due to its role as oxygen carrier, RBCs 
are particularly exposed to oxidative damage. G6PD patients 
therefore have an increased risk for RBC destruction due to 
oxidative stress which can be triggered by medication, illness, 
or certain foods such as fava beans. In addition to RBC defects 
affecting antioxidant defense hereditary, RBC disorders such as 
thalassemias and hemoglobinopathies also show increased oxi-
dative stress (129, 130). Besides inadequate ROS detoxification 
free heme and iron may as well give rise to enhanced oxidative 
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stress since partially oxygenated hemoglobin is susceptible to 
redox reactions (118, 131). In all these diseases, high levels of 
anti-band 3 antibodies and C3b are found bound to RBCs (132, 
133). Increased RBC phagocytosis is observed which can be 
ameliorated in many patients by a splenectomy (124).
Besides their role in genetic RBC defects, anti-band 3 anti-
bodies are also said to be important in RBC clearance during 
malarial infections (115, 134, 135). Infected RBCs demonstrate 
hemichrome binding to band 3 followed by band 3 clustering 
and opsonization with Nabs and complement (135, 136). Sickle 
cell trait, thalassemia trait, and G6PD-deficient individuals are 
known to have a selective advantage with respect to malarial 
infections. RBCs of these patients are more sensitive to oxida-
tive stress exerted by the malaria parasite (124). Already in early 
stages of the infection, RBCs are opsonized with Nabs, which 
may be one of the many reasons that malaria infections are more 
efficiently cleared in these patients.
PS-MeDiATeD RBC CLeARANCe
A second mechanism that has been proposed to be important 
for RBC removal is PS exposure at the cell surface of the RBC. 
In healthy RBCs, PS is located on the inner leaflet of the RBC 
membrane (137). On the outer leaflet of the RBC, PS exposure 
is suggested to be an “eat me” signal that triggers phagocytosis 
by macrophages. PS exposure can be induced by an increase in 
cytosolic Ca2+ concentration, which can be a result of oxidative 
stress, osmotic shock, or other forms of cell stress (138). PS 
exposure as a signal for clearance is not restricted to RBCs but 
is seen as a general removal signal of senescent or damaged cells. 
In nucleated cells, PS exposure is part of the apoptotic process. 
Since RBCs are non-nucleated cells, apoptosis does not occur, but 
the regulated process of cell death in RBC has been given the 
term eryptosis (139). PS-dependent apoptotic cell phagocytosis 
is evolutionary conserved and not only found in mammals but 
also in lower organisms such as C. elegans and Drosophila (140). 
Macrophages display an array of receptors for PS including Tim-
1, Tim-4, Stabilin-2, and CD300 (141–144). Furthermore, there 
are various bridging molecules, which can bind to PS on the cell 
surface, such as lactadherin, GAS-6, and protein S. These pro-
teins than facilitate binding to αvβ3/5 integrins or TAM receptors, 
respectively, on the macrophage and thereby induce clearance of 
PS-exposing RBCs (145).
PS-MeDiATeD RBC CLeARANCe iN 
DiSeASe
There is a multitude of diseases associated with PS-mediated RBC 
clearance. Some examples of pathologies where increased oxida-
tive stress activates Ca2+ cation channels and thereby induces 
PS exposure and eryptosis are sickle cell anemia, thalassemia, 
G6PD, iron deficiency, chronic kidney disease, and diabetes 
(138). Other diseases that are postulated to result in eryptosis are 
malignancies, cytostatic drug-induced anemia, hepatic failure, 
heart failure, and dehydration (138). PS exposure induced by the 
malaria parasite has been widely investigated. To ensure patho-
gen survival, Plasmodium falciparum activates oxidant-sensitive 
ion channels in the RBC membrane by inducing oxidative stress. 
These channels facilitate cellular uptake of nutrients, Na+ and 
Ca2+, and waste removal, which are crucial for parasite survival, 
yet a secondary concequence is PS exposure (146, 147). It has 
been suggested that P. falciparum prolongs RBC lifespan by 
sequestrating Ca2+ and digesting hemoglobin to diminish RBC 
swelling and preserve osmotic stability in the RBC (138, 148). 
The genetic resistance toward malaria infections found in sickle 
cell trait, thalassemia trait, and G6PD-deficient individuals has 
partially been attributed to the sensitivity of their RBC to induce 
PS exposure and erypotosis upon infection with as a result accel-
erated clearance of infected RBCs (149).
CD47-MeDiATeD RBC CLeARANCe
Although there is still debate on the exact nature of “eat me” 
signals on RBC membrane, it has been generally accepted that 
CD47 is a “don’t eat me” signal that plays a crucial role in RBC 
homeostasis (150, 151). CD47 is a ubiquitously expressed protein 
that binds the inhibitory receptor signal-regulatory protein alpha 
(SIRPα) present on macrophages but also other myeloid cells. 
The CD47–SIRPα interaction inhibits immune responses such as 
phagocytosis (152). The strong negative signal for phagocytosis 
brands CD47 a marker of “self ” (150). Besides functioning as a 
“don’t eat me” signal, our group has shown that a conformational 
change in the CD47 protein can switch the molecule from a “don’t 
eat me” to an “eat me” signal (117). This conformational change 
in CD47 can be induced by oxidative stress and promotes TSP-1 
binding to CD47, which creates a novel binding site for SIRPα. 
This alternative binding site for SIRPα induces a pro/phagocytic 
signal for the phagocyte. The dual role of CD47–SIRPα in 
regulating RBC uptake demonstrates the complexity of RBC 
clearance (117).
CD47-MeDiATeD RBC CLeARANCe iN 
DiSeASe
The role of CD47 as a “don’t eat me” or as an “eat me” signal in 
RBC clearance in pathological conditions is still rather unclear. It 
has been suggested that anemia in untreated Gaucher disease can 
be partly explained by reduced expression of CD47 on RBCs (153, 
154). In mice, it has been shown that CD47–SIRPα interactions 
have a profound effect on disease severity of autoimmune hemo-
lytic anemia (AIHA) (155). However, in human, AIHA patients’ 
CD47 expression is normal (156, 157). In sickle cell disease, CD47 
expression is not significantly altered in patients compared to 
healthy controls. Nonetheless, hydroxyurea, a commonly used 
therapy, induces overexpression of CD47 on RBCs (158). How 
CD47 expression is influenced in human infection models is 
mostly unknown. Yi et al. showed that the absence of CD47 on 
RBCs may be important for the process of detecting and mount-
ing an immune response against infected RBCs. They showed that 
the lack of CD47 on RBCs activates dendritic cells which in turn 
stimulate CD4+ T cells and antibody responses (159). Chambers 
et  al. show that in  vitro exposure of RBC to P. falciparum has 
no effect on CD47 expression (160). Yet, interfering with the 
CD47–SIRPα interaction might be a promising therapeutic 
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strategy in the control of malaria infections. Ayi et al. show that 
disrupting the CD47–SIRPα interaction enhances phagocytosis 
of infected RBCs (161). Moverover, Banerjee et al. demonstrated 
that Plasmodium yoelii preferentially infects RBCs expressing 
high levels of CD47 and that CD47−/− is highly resistant to P. yoelii 
infections (162). In contrast to Chambers et al., these authors do 
find reduced CD47 expression on human P. falciparum-infected 
RBCs. All in all, the role of CD47 in pathological situation is still 
largely unknown. It is apparent that RBC clearance is a complex 
and multifactorial process that can be influenced by numerous 
factors such as, inflammation, infection, chemical substances, 
oxidative stress, or osmotic imbalance. Eventually, the balance 
between “eat me” and “don’t eat me” signals will determine if an 
RBC gets cleared from the circulation or not.
CONCLUDiNG ReMARKS
The interplay between macrophages and RBC shapes RBC forma-
tion, repair, and clearance. The intricate molecular mechanisms 
driving these processes are only partially understood. These 
mechanisms are plastic and differ greatly between steady-state 
and pathological conditions. In SCD, thalassemia, or hemolytic 
anemia, the body cannot always cope with the adverse effects 
observed. Modulating the interaction between macrophages 
and developing erythroblasts has already been shown to lead to 
favorable results. An example of this is the study by Chow et al. 
where depletion of CD169+ macrophages was found to normal-
ize erythropoiesis in PV (16). Therefore, studying alternative 
mechanisms to fine-tune erythropoiesis and erythrophagocytosis 
in disease is important in reducing the clinical symptoms of 
several RBC-related diseases.
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